IMAGE:  February 2003 GRAPHIC:  University of Chicago Magazine
 
APRIL 2003
Volume 95, Issue 4
 
 
   
LINK:  Research
Investigations  
Citations  
Course Work  
Next Generation  
Original Source  
Fig.1  
 
LINK:  Features
Unexpected Expertise  
Poetic Justice  
Survival of the Richest
Food-Court Press  

Clouding the Issues

 

LINK:  Class Notes
Alumni News  
Alumni Works  
Deaths  

LINK:  Campus News
Chicago Journal  
University News  
Uchicago.edu e-bulletin  

LINK:  Also in every issue
Editor's Notes  
Letters  
From the President  
Chicagophile  

GRAPHIC:  ResearchInvestigations
An answer to the stem-cell debate?

Scarce, flexible forms of stem cells needed for medical research and treatment may become both simple to produce and plentiful with a new technology developed at Argonne National Laboratory—and the source is as close as your own bloodstream.

These “pluripotent” stem cells—which get their name because they can morph into a variety of cell types—can generate all types of body tissues. Although previously these cells had been found only in fetal tissue, which is limited, and bone marrow, which is difficult to collect, the new technology can produce them from adult blood cells.

Argonne scientist and University of Chicago professor of molecular genetics Eli-ezer Huberman and his colleagues, Yong Zhao and David Glesne, PhD’95, found that when adult monocytes—white blood cells formed in bone marrow—were exposed to a growth factor, they created a set of pluripotent stem cells. After cultivating the cells, the scientists added more growth factors, causing the stem cells to differentiate into nerve, liver, and immune-system tissue.

The finding, published in the March 4 Proceedings of the National Academy of Sciences, may offer researchers a practical alternative to the controversial use of embryonic stem cells for research, drug discovery, and transplantation.

The stem cells could be particularly useful in transplantation therapy, which replenishes immune cells that have been eradicated by cancer therapy or replaces neuronal tissue damaged during spinal-cord injury, stroke, or Alzheimer’s or Parkinson’s disease.

The research was funded by the National Institutes of Health, and Huberman and his crew have applied to patent the new technology. Argonne is run by the University as part of the U.S. Energy Department’s national laboratory system.

—Catharine Foster


 

 

Contact Advertising About the Magazine Alumni UChicago Archives
uchicago 2003 The University of Chicago Magazine 5801 South Ellis Ave., Chicago, IL 60637
phone: 773/702-2163 fax: 773/702-0495 uchicago-magazine@uchicago.edu